November is National Family Caregivers Month!

Innovations in Care

We provide access to support and programs that empower the lives of people living with neuromuscular diseases.

Gene Therapy Series Part 2: Understanding the Insurance Process & What’s New in Gene Therapy Across NM

September 5th, 2024
Live, Virtual Webinar

This webinar is the second of our three-part series on gene therapy across neuromuscular diseases.

Watch On Demand

Ver en español

Download Insurance Guide

Learn from experts about the complex insurance process related to gene therapy including how to understand insurance benefits, treatment criteria, and how to file an appeal. Presenters will also share timely information about public policies related to insurance coverage and gene therapy.

The featured speakers for this first presentation will be Michael Storey, PharmD, MS from Nationwide Children's Hospital and Paul Melmeyer, Vice President of Public Policy & Advocacy at Muscular Dystrophy Association.

Next, attendees will learn about other gene therapies in the pipeline across different neuromuscular diseases and how advancements in one disease are leading to progress in others. This presentation will share information that is relevant to the entire neuromuscular community.

The featured speaker for this presentation will be Barry J. Byrne, MD, PhD, Director of Powell Gene Therapy Center at the University of Florida.

Faculty: 
Michael Storey
PharmD, MS

Nationwide Children's Hospital

Paul Melmeyer
Vice President of Public Policy & Advocacy

MDA

Barry Byrne
MD, PhD, Director

Powell Gene Therapy Center at University of Florida